Molecular remissions are observed in chronic adult T-cell leukemia/lymphoma in patients treated with mogamulizumab

Haematologica. 2019 Dec;104(12):e566-e569. doi: 10.3324/haematol.2019.219253. Epub 2019 Apr 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Chronic Disease
  • Clinical Trials as Topic
  • Humans
  • Leukemia-Lymphoma, Adult T-Cell / drug therapy*
  • Leukemia-Lymphoma, Adult T-Cell / pathology
  • Prognosis
  • Remission Induction

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • mogamulizumab